Clinical Trial Update: dTMS for Subjective Cognitive Decline [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating deep transcranial magnetic stimulation (dTMS) for subjective cognitive decline and Alzheimer's disease. Sponsor is Rot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Subjective Cognitive Decline

Snippet

Sponsor: Rotman Research Institute at Baycrest | Conditions: Alzheimer Disease, Subjective Cognitive Decline | NA | Status: RECRUITING